Association of urinary polycyclic aromatic hydrocarbons and serum C-reactive protein

Inflammation, Atherosclerosis, and Coronary Artery Disease

2005 • 8,367 citations

Inflammation in atherosclerosis

2002 • 7,873 citations

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

2008 • 6,182 citations

Markers of Inflammation and Cardiovascular Disease

2003 • 6,067 citations

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

1997 • 5,442 citations

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

2009 • 3,737 citations

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

2002 • 3,483 citations

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

2000 • 1,703 citations

C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction

1998 • 1,033 citations

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

1993 • 624 citations

C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk

2007 • 593 citations

The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women

2006 • 507 citations

Bioavailability and Risk Assessment of Orally Ingested Polycyclic Aromatic Hydrocarbons

2004 • 467 citations

Particulate air pollution is associated with an acute phase response in men. Results from the MONICA–Augsburg Study

2001 • 399 citations

Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population

2008 • 294 citations

Polycyclic Aromatic Hydrocarbons in Urban Air Particulate Matter: Decadal and Seasonal Trends, Chemical Degradation, and Sampling Artifacts

2003 • 290 citations

Biomonitoring of polycyclic aromatic hydrocarbons in human urine

2002 • 250 citations

Combined Use of Computed Tomography Coronary Calcium Scores and C-Reactive Protein Levels in Predicting Cardiovascular Events in Nondiabetic Individuals

2002 • 221 citations

Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS)

2005 • 204 citations

C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease

2008 • 199 citations

Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons.

2000 • 189 citations

C-Reactive Protein and the Future Risk of Thromboembolic Stroke in Healthy Men

2003 • 176 citations

Measurement of Urinary Monohydroxy Polycyclic Aromatic Hydrocarbons Using Automated Liquid−Liquid Extraction and Gas Chromatography/Isotope Dilution High-Resolution Mass Spectrometry

2006 • 173 citations

Automated solid-phase extraction method for measuring urinary polycyclic aromatic hydrocarbon metabolites in human biomonitoring using isotope-dilution gas chromatography high-resolution mass spectrometry

2006 • 101 citations

Reference range levels of polycyclic aromatic hydrocarbons in the US population by measurement of urinary monohydroxy metabolites

2005 • 75 citations

Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation

2007 • 67 citations

Fiber and C-Reactive Protein in Diabetes, Hypertension, and Obesity

2005 • 59 citations

Effect of Psyllium Fiber Supplementation on C-Reactive Protein: The Trial to Reduce Inflammatory Markers (TRIM)

2008 • 53 citations

Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population

2006 • 34 citations

Introduction: Atherosclerosis as inflammation: a controversial concept becomes accepted

2008 • 28 citations

Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy

2006 • 24 citations